| EP3399964 - CYCLOSPORINE A TOPICAL COMPOSITIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.07.2020 Database last updated on 07.04.2026 | |
| Former | Grant of patent is intended Status updated on 11.08.2019 | ||
| Former | Request for examination was made Status updated on 12.10.2018 | ||
| Former | The international publication has been made Status updated on 14.07.2017 | ||
| Former | unknown Status updated on 13.01.2017 | Most recent event Tooltip | 10.07.2020 | Application deemed to be withdrawn | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states Spherium Biomed S.L. Av. Diagonal 549, 5p. 08029 Barcelona / ES | For all designated states Bionanoplus, S.L. Polígono Mocholí Plaza Cein, 5 - nave B14 31110 Noáin- Navarra / ES | [2018/46] | Inventor(s) | 01 /
SALMAN, Hesham H.A. Bionanoplus S.L. Pol. Mocholí Plaza Cein 5 Nave B14 E-31110 Noáin -Navarra / ES | 02 /
ESPARZA CATALÁN, Irene Bionanoplus S.L. Pol. Mocholí Plaza Cein 5 Nave B14 E-31110 Noáin -Navarra / ES | 03 /
SANTOS LOBO, Benjamín Spherium Biomed S.L. Joan XXIII, 10 E-08950 Esplugues de Llobregat-Barcelona / ES | 04 /
LLUCH, Nuria Spherium Biomed, S.l. Joan XXIII, 10 E-08950 Esplugues de Llobregat-Barcelona / ES | [2019/37] |
| Former [2018/46] | 01 /
SALMAN, Hesham H.A. Bionanoplus S.L. Pol. Mocholí Plaza Cein 5 Nave B14 E-31110 Noáin -Navarra / ES | ||
| 02 /
ESPARZA CATALÁN, Irene Bionanoplus S.L. Pol. Mocholí Plaza Cein 5 Nave B14 E-31110 Noáin (Navarra) / ES | |||
| 03 /
SANTOS LOBO, Benjamín Spherium Biomed S.L. Joan XXIII 10 E-08950 Esplugues de Llobregat (Barcelona) / ES | |||
| 04 /
LLUCH, Nuria Spherium Biomed S.l. Joan XXIII 10 E-08950 Esplugues de Llobregat-Barcelona / ES | Representative(s) | ABG Intellectual Property Law, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | [N/P] |
| Former [2018/46] | ABG Intellectual Property, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | Application number, filing date | 17700019.7 | 03.01.2017 | [2018/46] | WO2017EP50059 | Priority number, date | EP20160382001 | 04.01.2016 Original published format: EP 16382001 | [2018/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017118622 | Date: | 13.07.2017 | Language: | EN | [2017/28] | Type: | A1 Application with search report | No.: | EP3399964 | Date: | 14.11.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.07.2017 takes the place of the publication of the European patent application. | [2018/46] | Search report(s) | International search report - published on: | EP | 13.07.2017 | Classification | IPC: | A61K9/107, A61K38/13 | [2018/46] | CPC: |
A61K38/13 (EP,KR,US);
A61K9/1075 (EP,KR,US);
A61K47/10 (KR,US);
A61K47/14 (US);
A61K47/26 (US);
A61K47/32 (KR,US);
A61K9/0014 (KR,US);
A61P17/00 (EP,KR,US);
A61P17/06 (KR);
A61P37/08 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/46] | Title | German: | TOPISCHE ZUSAMMENSETZUNGEN MIT CYCLOSPORIN A | [2018/46] | English: | CYCLOSPORINE A TOPICAL COMPOSITIONS | [2018/46] | French: | COMPOSITIONS TOPIQUES DE CYCLOSPORINE A | [2018/46] | Entry into regional phase | 06.07.2018 | National basic fee paid | 06.07.2018 | Designation fee(s) paid | 06.07.2018 | Examination fee paid | Examination procedure | 06.07.2018 | Amendment by applicant (claims and/or description) | 06.07.2018 | Examination requested [2018/46] | 06.07.2018 | Date on which the examining division has become responsible | 12.08.2019 | Communication of intention to grant the patent | 03.01.2020 | Application deemed to be withdrawn, date of legal effect [2020/33] | 24.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2020/33] | Fees paid | Renewal fee | 13.12.2018 | Renewal fee patent year 03 | 27.01.2020 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A] WO2014189251 (TAEJOON PHARM CO LTD et al.) | [A] US5962017 (HAUER BIRGIT et al.) | [A] WO0128520 (VESIFACT AG et al.) | [A] US2007015691 (CHANG JAMES N et al.) | by applicant | US8642556 | US8629111 | US8618064 | US8633162 | US8648048 | US8685930 | US5891846 | AMOR ET AL., J. AM. ACAD. DERMATOL., vol. 63, 2010, pages 925 - 946 | AMOR ET AL., J. AM. ACAD. DERMATOL.,, vol. 63, 2010, pages 925 - 946 | KOVALIK ET AL., THE VETERINARY JOURNAL, vol. 193, 2012, pages 317 - 325 | PALMEIRO, VET. CLIN. SMALL ANIM., vol. 43, 2013, pages 154 - 171 | CARIDI ET AL.: "Topical Calcineurin Inhibitors in the Treatment of Vitiligo in Bitiligo - Management and Therapy", 2001 | GODDERERIS C. ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 312, 2006, pages 187 - 195 | GRIFFIN, JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, vol. 1, 1949, pages 311 - 326 | "Handbook of pharmaceutical excipients", 2009, THE PHARMACEUTICAL PRESS |